PHARMACEUTICAL COMPOSITIONS COMPRISING IMMUNOLOGICAL FORMULATIONS FOR TREATING CEREBRAL INFARCTION

摘要

PROBLEM TO BE SOLVED: To provide pharmaceutical compositions for treating cerebral infarction administrable to patients in a post-acute stage of cerebral infarction.;SOLUTION: The invention provides a pharmaceutical composition for treating cerebral infarction, comprising a thrombolytic agent and an inhibitor that inhibits the binding of a vascular endothelial growth factor (VEGF) to a receptor thereof. The pharmaceutical composition of the invention for treating cerebral infarction may be administered to a patient after a post-acute stage of cerebral infarction. The pharmaceutical composition of the invention for treating cerebral infarction may contain a tissue type plasminogen activator (t-PA) or a derivative thereof. The pharmaceutical composition of the invention for treating cerebral infarction may contain an anti-VEGF-A neutralizing antibody or a derivative thereof.;SELECTED DRAWING: None;COPYRIGHT: (C)2019,JPO&INPIT